An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
BIONIK Laboratories Corp. to Present at Investor Summit Group’s Q3 Virtual Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
BIONIK Laboratories Corp. (OTC Pink: BNKL) is set to present at the Q3 Virtual Investor Summit on August 16, 2022 at 2:45 PM ET. Rich Russo, the CFO and Interim CEO, will provide a corporate overview and connect with institutional investors. This summit, featuring over 90 companies and 500 investors, focuses on various sectors including healthcare and technology. Qualified investors can register for complimentary access to the event. For more information, visit www.BIONIKlabs.com.
Positive
None.
Negative
None.
Presentation on Tuesday, August 16th at 2:45pm ET
BOSTON--(BUSINESS WIRE)--
BIONIK Laboratories Corp. (OTC Pink: BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced that Rich Russo, Chief Financial Officer and Interim Chief Executive Officer, will be presenting a corporate overview and meeting with institutional investors at the Q3 Virtual Investor Summit.
BIONIK Laboratories is a robotics company focused on providing rehabilitation and mobility solutions to individuals with neurological and mobility challenges from hospital to home. The Company has a portfolio of products focused on upper and lower extremity rehabilitation for stroke and other mobility-impaired patients, including three products on the market and three products in varying stages of development.
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q3 Investor Summit will take place virtually, featuring 90+ companies and over 500 investors comprising institutional investors, family offices, and high net worth investors. Sectors Participating: Biotech, Communication Services, Consumer, Energy, Energy/Tech, Financial, Healthcare, Industrials, Materials, Real Estate, Technology, and Tech/Crypt.
When will BIONIK Laboratories present at the Investor Summit?
BIONIK Laboratories Corp. will present on August 16, 2022, at 2:45 PM ET.
Who is presenting for BIONIK Laboratories at the Investor Summit?
Rich Russo, CFO and Interim CEO, will present for BIONIK Laboratories at the Investor Summit.
What is the Q3 Investor Summit?
The Q3 Investor Summit is a virtual conference connecting smallcap and microcap companies with qualified investors, featuring over 90 companies and 500 investors.
How can qualified investors register for the Q3 Investor Summit?
Qualified investors can register for complimentary access to the Q3 Investor Summit through the designated registration link provided in the press release.
What does BIONIK Laboratories focus on?
BIONIK Laboratories focuses on providing rehabilitation and assistive technology solutions for individuals with neurological and mobility challenges.
